Back to Report Store Home

Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2024 – Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market

  • Published: Jul-2018
  • Report Code: GBIHC480MR
  • Report Format: pdf

Description

List of Figures

Figure 1: CRC Therapeutics Market, Australia, Age-Specific Incidence and Mortality Rate (per 100,000) in 2013 11

Figure 2: CRC Therapeutics, Treatment Algorithm for mCRC 25

Figure 3: CRC Therapeutics Market, Comparative Efficacy and Safety Heatmap for Marketed Products, 2018 41

Figure 4: CRC Therapeutics Market, Comparative Efficacy and Safety Heatmap for First-line Marketed Products, 2018 42

Figure 5: CRC Therapeutics Market, Comparative Efficacy and Safety Heatmap for Second-line Marketed Products, 2018 43

Figure 6: CRC Therapeutics Market, Comparative Efficacy and Safety Heatmap for Third or Fourth-line Marketed Products, 2018 43

Figure 7: CRC Therapeutics Market, Global, Pipeline, 2018 46

Figure 8: CRC Therapeutics Market, Global, Pipeline by Molecular Target, 2018 48

Figure 9: CRC Therapeutics Market, Pipeline by Molecular Target and Stage of Development, 2018 49

Figure 10: CRC Therapeutics Market, APAC, Keytruda Forecast ($m), 2020–2024 51

Figure 11: CRC Therapeutics Market, APAC, Opdivo Forecast ($m), 2023–2024 53

Figure 12: CRC Therapeutics Market, APAC, Napabucasin Forecast ($m), 2022–2024 55

Figure 13: CRC Therapeutics Market, APAC, Encorafenib plus Binimetinib Forecast ($m), 2021–2024 57

Figure 14: CRC Therapeutics Market, APAC, Fruquintinib Forecast ($m), 2018–2024 58

Figure 15: CRC Therapeutics Market, APAC, Famitinib Forecast ($m), 2021–2024 59

Figure 16: CRC Therapeutics Market, APAC, Anlotinib Forecast ($m), 2020–2024 60

Figure 17: CRC Therapeutics Market, APAC, Donafenib Forecast ($m), 2021–2024 61

Figure 18: CRC Therapeutics Market, Comparative Efficacy and Safety Heatmap for Pipeline Products, 2018 61

Figure 19: CRC Therapeutics Market, Competitor Matrix for CRC Marketed and Pipeline Products, 2018 63

Figure 20: CRC Therapeutics, Global, Average Clinical Trial Failure Rate (%), 2007–2017 65

Figure 21: CRC Therapeutics, Global, Clinical Trial Failure Rates by Molecule Type (%), 2007–2017 66

Figure 22: CRC Therapeutics, Global, Clinical Trial Failure Rates by Molecular Target (%), 2007–2017 67

Figure 23: CRC Therapeutics, Global, Clinical Trial Size per Product by Molecule Type (participants), 2007–2017 68

Figure 24: CRC Therapeutics, Global, Clinical Trial Size per Product by Molecular Target (participants), 2007–2017 69

Figure 25: CRC Therapeutics, Global, Clinical Trial Size per Trial by Molecule Type (participants), 2007–2017 70

Figure 26: CRC Therapeutics, Global, Clinical Trial Size per Trial by Molecular Target (participants), 2007–2017 71

Figure 27: CRC Therapeutics, Global, Clinical Trial Duration by Molecule Type (months), 2007–2017 72

Figure 28: CRC Therapeutics, Global, Clinical Trial Duration by Molecular Target (months), 2007–2017 73

Figure 29: CRC Therapeutics Market, Global, Comparison of Average Trial Metrics by Phase and Molecule Type 74

Figure 30: CRC Therapeutics Market, Global, Comparison of Average Trial Metrics by Phase and Molecular Target 74

Figure 31: CRC Therapeutics Market, APAC, Treatment Patterns (‘000), 2017–2024 76

Figure 32: CRC Therapeutics Market, APAC, Market Size ($bn), 2017–2024 76

Figure 33: CRC Therapeutics Market, India, Treatment Patterns (‘000), 2017–2024 77

Figure 34: CRC Therapeutics Market, India, Annual Cost of Therapy ($), 2017–2024 78

Figure 35: CRC Therapeutics Market, India, Market Size ($m), 2017–2024 79

Figure 36: CRC Therapeutics Market, China, Treatment Patterns (‘000), 2017–2024 80

Figure 37: CRC Therapeutics Market, China, Annual Cost of Therapy ($), 2017–2024 81

Figure 38: CRC Therapeutics Market, China, Market Size ($bn), 2017–2024 82

Figure 39: CRC Therapeutics Market, Australia, Treatment Patterns (‘000), 2017–2024 83

Figure 40: CRC Therapeutics Market, Australia, Annual Cost of Therapy ($), 2017–2024 84

Figure 41: CRC Therapeutics Market, Australia, Market Size ($m), 2017–2024 85

Figure 42: CRC Therapeutics Market, South Korea, Treatment Patterns (‘000), 2017–2024 86

Figure 43: CRC Therapeutics Market, South Korea, Annual Cost of Therapy ($), 2017–2024 87

Figure 44: CRC Therapeutics Market, South Korea, Market Size ($m), 2017–2024 88

Figure 45: CRC Therapeutics Market, Japan, Treatment Patterns (‘000), 2017–2024 89

Figure 46: CRC Therapeutics Market, Japan, Annual Cost of Therapy ($), 2017–2024 90

Figure 47: CRC Therapeutics Market, Japan, Market Size ($bn), 2017–2024 90

Figure 48: CRC Therapeutics Market, Global, Licensing Deals by Region and Value, 2007–2018 96

Figure 49: CRC Therapeutics Market, Global, Number of Disclosed and Undisclosed Licensing Deals by Year, Aggregate Deal Value and Aggregate Upfront Payment Value, 2007–2018 97

Figure 50: CRC Therapeutics Market, Global, Licensing Deals by Stage of Development, Deal Value and Upfront Payment Value, 2007–2018 98

Figure 51: CRC Therapeutics Market, Global, Licensing Deals by Molecule Type and Stage of Development, 2007–2018 99

Figure 52: CRC Therapeutics, Global, Licensing Deals by Molecular Targets and Aggregate Deal Value ($), 2007–2018 100

Figure 53: CRC Therapeutics Market, Global, Co-development Deals by Region and Deal Value, 2007–2018 103

Figure 54: CRC Therapeutics Market, Global, Number of Disclosed and Undisclosed Co-development Deals by Year, Aggregate Deal Value and Aggregate Upfront Payment Value, 2007–2018 104

Figure 55: CRC Therapeutics Market, Global, Co-development Deals by Stage of Development, Deal Value and Upfront Payment Value, 2007–2018 105

Figure 56: CRC Therapeutics Market, Global, Co-development Deals by Molecule type and Stage of Development, 2007–2018 106

Figure 57: CRC Therapeutics Market, Global, Co-development Deals by Molecular Target, 2007–2018 107

 
      captcha refresh

I have read and accept terms and conditions and privacy policy

Cancel
License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$4995
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$9990
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$14985
Email to a colleague Request Sample Pages Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards